Zobrazeno 1 - 10
of 180
pro vyhledávání: '"John Floyd"'
Autor:
Andrew J. Brenner, John Floyd, Lisa Fichtel, Joel Michalek, Kunal P. Kanakia, Shiliang Huang, David Reardon, Patrick Y. Wen, Eudocia Quant Lee
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
Abstract Evofosfamide (Evo or TH302) is a hypoxia-activated prodrug which is reduced leading to the release of alkylating agent bromo-isophosphoramide mustard, which has shown safety and signals of efficacy in a prior phase 1 study in recurrent gliob
Externí odkaz:
https://doaj.org/article/16ef77b4456d40deafd54338f2c50ae9
Publikováno v:
Case Reports in Otolaryngology, Vol 2018 (2018)
We present a case of an oropharyngeal cerebrospinal fluid (CSF) fistula in a patient that presented with headache, rhinorrhea, and pneumocephalus years after an anterior cervical discectomy and fusion. Imaging suggested a defect in the fovea ethmoida
Externí odkaz:
https://doaj.org/article/615c096592b14fe8802c0c5b57e29f0d
Autor:
Pratley, Pierre, Sandberg, John Floyd
Publikováno v:
Social Indicators Research, 2018 Nov 01. 140(2), 777-793.
Externí odkaz:
https://www.jstor.org/stable/48715080
Autor:
William Kelly, Adolfo Enrique Diaz Duque, Joel Michalek, Brandon Konkel, Laura Caflisch, Yidong Chen, Sarath Chand Pathuri, Vinu Madhusudanannair-Kunnuparampil, John Floyd, Andrew Brenner
Publikováno v:
Clinical Cancer Research. :OF1-OF7
Purpose: Glioblastoma represents the most common primary brain tumor. Although antiangiogenics are used in the recurrent setting, they do not prolong survival. Glioblastoma is known to upregulate fatty acid synthase (FASN) to facilitate lipid biosynt
Publikováno v:
Cancer Research. 83:P1-14
Purpose: Sacituzumab govitecan has shown efficacy and acceptable tolerability in a multicenter phase I/II clinical trial (NCT01631552) in patients with advanced epithelial cancers. Our study was initiated to determine the bioavailability of Sacituzum
Autor:
Andrew Brenner, John Floyd, Vinu Madhusudanannair-Kunnuparampil, Sarath Chand Pathuri, Yidong Chen, Laura Caflisch, Brandon Konkel, Joel Michalek, Adolfo Enrique Diaz Duque, William Kelly
Representativeness of Study Participants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46e609cdfa6edf1ea970dc0868baed67
https://doi.org/10.1158/1078-0432.22787533
https://doi.org/10.1158/1078-0432.22787533
Autor:
Andrew Brenner, John Floyd, Vinu Madhusudanannair-Kunnuparampil, Sarath Chand Pathuri, Yidong Chen, Laura Caflisch, Brandon Konkel, Joel Michalek, Adolfo Enrique Diaz Duque, William Kelly
RNA Analysis Summary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::150cc28997409d645fe37c1960c3db52
https://doi.org/10.1158/1078-0432.22787521
https://doi.org/10.1158/1078-0432.22787521
Autor:
Andrew Brenner, John Floyd, Vinu Madhusudanannair-Kunnuparampil, Sarath Chand Pathuri, Yidong Chen, Laura Caflisch, Brandon Konkel, Joel Michalek, Adolfo Enrique Diaz Duque, William Kelly
CONSORT flow diagram with patient disposition and treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82ca84cb2bcbf30baa92e914e25e4e86
https://doi.org/10.1158/1078-0432.22787542
https://doi.org/10.1158/1078-0432.22787542
Autor:
Andrew Brenner, John Floyd, Vinu Madhusudanannair-Kunnuparampil, Sarath Chand Pathuri, Yidong Chen, Laura Caflisch, Brandon Konkel, Joel Michalek, Adolfo Enrique Diaz Duque, William Kelly
Exosome Analysis Summary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c279722b8a05f606493f51c759da9f2
https://doi.org/10.1158/1078-0432.22787524
https://doi.org/10.1158/1078-0432.22787524
Autor:
Andrew Brenner, John Floyd, Vinu Madhusudanannair-Kunnuparampil, Sarath Chand Pathuri, Yidong Chen, Laura Caflisch, Brandon Konkel, Joel Michalek, Adolfo Enrique Diaz Duque, William Kelly
Purpose:Glioblastoma represents the most common primary brain tumor. Although antiangiogenics are used in the recurrent setting, they do not prolong survival. Glioblastoma is known to upregulate fatty acid synthase (FASN) to facilitate lipid biosynth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f47d071b68a2b6a1f1acbd324e2f112
https://doi.org/10.1158/1078-0432.c.6637741.v1
https://doi.org/10.1158/1078-0432.c.6637741.v1